Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Biogen Inc. (BIIB) (BIIB)

321.05   4.1 (1.29%) 04-09 16:00
Open: 315.1 Pre. Close: 316.95
High: 322.45 Low: 314.01
Volume: 1,461,861 Market Cap: 55883M
Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 322.869 - 324.174 324.174 - 325.417
Low: 310.776 - 312.218 312.218 - 313.592
Close: 318.729 - 321.003 321.003 - 323.169

Technical analysis

as of: 2020-04-09 4:28:16 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 376.62     One year: 439.89
Support: Support1: 285.25    Support2: 262.25
Resistance: Resistance1: 322.45    Resistance2: 376.62
Pivot: 299.48
Moving Average: MA(5): 310.22     MA(20): 298.56
MA(100): 301.38     MA(250): 263.24
MACD: MACD(12,26): 2.19     Signal(9): -1.01
Stochastic oscillator: %K(14,3): 85.33     %D(3): 79.00
RSI: RSI(14): 55.79
52-week: High: 374.99  Low: 215.78  Change(%): 36.9
Average Vol(K): 3-Month: 219604  10-Days: 219952

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
BIIB has closed below upper band by 15.6%. Bollinger Bands are 48.3% wider than normal. The large width of the bands suggest high volatility as compared to BIIB's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

Sangamo Announces Closing of Biogen Collaboration Agreement
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced the closing of its previously announced sale of stock to Biogen Inc. (Nasdaq: BIIB) and that the global licensing collaboration agreement with Biogen for the development and commercialization of gene regulation therapies for Alzheimer’s, Parkinson’s, neuromuscular and other neurological diseases is now effective. Under the terms of the collaboration, Sangamo has received $22

Biogen Inc (NASDAQ: BIIB) Q4 2019 Earnings Call Transcript | AlphaStreet
Final earnings conference call transcript of Biogen Inc - BIIB stock

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 174.06
Shares Float (M) 173.05
% Held by Insiders 0.63
% Held by Institutions 90.28
Shares Short (K) 3140
Shares Short P. Month (K) 3110

Stock Financials

EPS 31.420
Book Value (p.s.) 76.600
PEG Ratio 6.49
Profit Margin 40.96
Operating Margin 50.60
Return on Assets (ttm) 17.3
Return on Equity (ttm) 44.7
Qtrly Rev. Growth 4.1
Gross Profit (p.s.) 71.355
Sales Per Share 82.615
EBITDA (p.s.) 44.467
Qtrly Earnings Growth 52.10
Operating Cash Flow (M) 7080.00
Levered Free Cash Flow (M) 4640.00

Stock Valuations

P/E 10.22
P/E Growth Ratio 0.01
P/BV 4.19
P/CF 7.89

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio 3
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.